An orphan drug is a pharmaceutical agent that is developed to treat certain rare medical conditions. An orphan drug would not be profitable to produce...

The Orphan Drug Act of 1983 is a law passed in the United States to facilitate development of orphan drugs—drugs for rare diseases such as Huntington's...

financial incentives from governments or other agencies. Orphan drugs are medications targeting orphan diseases. Most rare diseases are genetic in origin and...

and Drug Administration. Archived from the original on 7 April 2020. Retrieved 31 May 2007. "The Orphan Drug Act (as amended)". U.S. Food and Drug Administration...

Because of preliminary data suggesting the drug may have activity, the U.S. FDA in 2013 granted tolcapone "orphan drug status" in studies aiming at the treatment...

up orphan in Wiktionary, the free dictionary. An orphan is one who has lost both parents. Orphan(s) or The Orphan(s) may also refer to: The Orphan (1960...

approved orphan drugs. An orphan drug may cost as much as $400,000 annually. Monopolizing orphan drugs has proven to be a very profitable strategy for drug companies;...

increased to 200. Specialty drugs may also be designated as orphan drugs or ultra-orphan drugs under the U. S. Orphan Drug Act of 1983. This was enacted...

large commercial success or public health effect can be expected, the orphan drug funding process ensures that people who experience those disorders can...

the first available treatment for neurotrophic keratitis, and received orphan drug designation. Cenegermin is marketed under the name Oxervate. In the same...